Healthcare of Ontario Pension Plan Trust Fund Purchases Shares of 30,900 Masimo Co. (NASDAQ:MASI)

Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Masimo Co. (NASDAQ:MASI - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 30,900 shares of the medical equipment provider's stock, valued at approximately $4,120,000. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.06% of Masimo at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Lazard Asset Management LLC boosted its holdings in Masimo by 5,730.0% in the first quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider's stock worth $85,000 after acquiring an additional 573 shares in the last quarter. Tidal Investments LLC lifted its stake in shares of Masimo by 14.1% in the first quarter. Tidal Investments LLC now owns 2,179 shares of the medical equipment provider's stock valued at $320,000 after buying an additional 269 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Masimo by 75.0% in the 2nd quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider's stock worth $33,000 after acquiring an additional 111 shares during the last quarter. Juncture Wealth Strategies LLC boosted its stake in Masimo by 294.3% during the 2nd quarter. Juncture Wealth Strategies LLC now owns 7,992 shares of the medical equipment provider's stock valued at $1,007,000 after purchasing an additional 5,965 shares during the last quarter. Finally, Cardinal Capital Management lifted its holdings in shares of Masimo by 4.6% in the second quarter. Cardinal Capital Management now owns 15,440 shares of the medical equipment provider's stock valued at $1,945,000 after purchasing an additional 676 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Up 1.0 %

MASI traded up $1.65 on Friday, hitting $172.54. The company had a trading volume of 240,979 shares, compared to its average volume of 680,424. The stock has a fifty day simple moving average of $149.24 and a 200-day simple moving average of $129.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The firm has a market capitalization of $9.24 billion, a P/E ratio of 118.99 and a beta of 0.97. Masimo Co. has a 52-week low of $91.60 and a 52-week high of $178.27.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The business had revenue of $504.60 million during the quarter, compared to analysts' expectations of $502.87 million. During the same quarter in the previous year, the business earned $0.63 earnings per share. The firm's quarterly revenue was up 5.4% compared to the same quarter last year. As a group, equities analysts expect that Masimo Co. will post 4.03 EPS for the current fiscal year.

Wall Street Analyst Weigh In

MASI has been the topic of a number of recent research reports. Piper Sandler upped their price target on Masimo from $165.00 to $180.00 and gave the company an "overweight" rating in a research report on Wednesday, November 6th. Raymond James upgraded shares of Masimo from a "market perform" rating to an "outperform" rating and set a $170.00 price objective for the company in a research note on Wednesday, November 6th. Needham & Company LLC restated a "hold" rating on shares of Masimo in a research report on Wednesday, November 6th. BTIG Research lifted their price target on Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Finally, Wells Fargo & Company increased their price objective on Masimo from $160.00 to $171.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Masimo has an average rating of "Moderate Buy" and an average price target of $167.00.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.